BBC Future profiles MAPS Founder Rick Doblin, Ph.D., in an extensive article exploring the international impact of psychedelics on science, drug policy, culture, and medicine.
By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance.
"Now the efforts of Doblin and others are finally paying off,” writes Prideaux. "Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction."
Read more
Psychedelic use on the rise as Gen Z seeks to ‘enhance connectedness’.
The latest data shows the highest rates of psychedelic use among college students since 1982.
Read more
‘The End In Mind’ conference answers questions about psychedelics for end-of-life patients.
Read more
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary.
Read more
What does ketamine do to your brain?
Much of how ketamine works is a mystery, but the picture is slowly coming into focus.
Read more
Psychedelic treatments are here, but doctors aren’t prepared.
So says Rick Doblin, founder and executive director of the Multidisciplinary Assn. for Psychedelic Studies.
Read more
A body of remarkable experiments have shown that fungi operate as individuals, engage in decision-making, are capable of learning, and possess short-term memory.
These findings highlight the spectacular sensitivity of such ‘simple’ organisms, and situate the human version of the mind within a spectrum of consciousness that might well span the entire natural world.
Read more
Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control and decision-making.
Read more